Literature DB >> 9476031

Amlodipine lowers blood pressure without increasing sympathetic activity or activating the renin-angiotensin system in patients with essential hypertension.

M Sasaguri1, N Matsumoto, K Noda, M Koga, A Kinoshita, M Ideishi, K Arakawa.   

Abstract

OBJECTIVE: Recent clinical studies suggest that the reflex increase in sympathetic nervous activity accompanying a reduction in blood pressure may contribute to the untoward effects of dihydropyridine calcium antagonists. The aim of this study was to examine whether plasma noradrenaline levels and renin activity are increased with the reduction of blood pressure during the initial phase of administration of the long-acting dihydropyridine calcium antagonist amlodipine.
METHODS: The effects of amlodipine on ambulatory blood pressure and on diurnal variations in plasma noradrenaline and renin activity were examined 1, 4, and 7 days after the start of amlodipine administration in eight inpatients with essential hypertension.
RESULTS: The 24-h mean systolic and diastolic blood pressure on day 7 was significantly lower than it was 1 day before the start of treatment. There was no change in the mean heart rate. The mean trough to peak ratios of systolic and diastolic blood pressure of seven patients were 61% and 71%, respectively. Diurnal patterns of plasma noradrenaline levels and renin activity 1, 4, and 7 days after the start of amlodipine administration were unchanged.
CONCLUSION: The antihypertensive effects of amlodipine were of slow onset and long duration and were not accompanied by an increase in sympathetic activity or activation of the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9476031     DOI: 10.1007/s002280050362

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  5 in total

Review 1.  Central sympathoinhibitory effects of calcium channel blockers.

Authors:  F H Leenen; M Ruzicka; B S Huang
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

Review 2.  Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: a literature review comparing amlodipine and nifedipine GITS.

Authors:  Corey B Toal; Peter A Meredith; Henry L Elliott
Journal:  Blood Press       Date:  2012-07-05       Impact factor: 2.835

Review 3.  Amlodipine as an antiischemic drug is superior to long acting nitrates.

Authors:  Goran P Koraćević; Sonja S Dakić; Radmila M Veličković-Radovanović; Svetlana R Apostolović; Nebojša H Krstić; Ivan S Tasić; Marija D Zdravković; Nebojša M Antonijević; Goran N Damnjanović; Tomislav L Kostić
Journal:  Open Med (Wars)       Date:  2014-11-03

4.  Comparison of short-acting versus extended-release nifedipine: Effects on hemodynamics and sympathetic activity in patients with stable coronary artery disease.

Authors:  John D Parker; Matthew D' Iorio; John S Floras; Corey B Toal
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

5.  Urine biomarkers of renal renin-angiotensin system activity: Exploratory analysis in humans with and without obstructive sleep apnea.

Authors:  Patrick J Hanly; Sofia Ahmed; Chris D Fjell; George B Handley; Darlene Sola; David Nicholl; Ann Zalucky
Journal:  Physiol Rep       Date:  2020-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.